Corvus Pharmaceuticals, Inc.

CRVS· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences

$12.56+0.08%

2026-09-18

Financials

Valuation Metrics

Corvus Pharmaceuticals, Inc.'s Market Cap is $1.06B. At end of 2025 it was $608M. Ranked #2448 of 3,121 in US market (top 78%), #997 of 1,463 on NASDAQ (top 68%), #185 of 266 in Pharmaceuticals, Biotechnology & Life Sciences (top 70%) by Market Cap.

Investment Metrics(as of 2026-09-18)

Metric	Value	Rank
Size
Market Cap	$1.06B	US#2,448/3,121 Sec#185/266
Revenue	$0.00	US#2,889/3,121 Sec#196/266
Net Income	$-54M	US—/3,121 Sec—/266
Total Assets	$239M	US#2,965/3,121 Sec#235/266
Net Assets	$225M	US#2,642/3,121 Sec#178/266
Value
P/B	4.69x	US#2,160/3,121 Sec#133/266
FCF Yield	-4.28%	US—/3,121 Sec—/266
Profitability
ROE	-24.02%	US#2,523/3,121 Sec#102/266
ROA	-22.62%	US#2,826/3,121 Sec#136/266
Financial Health
Debt Ratio	6.19%	US#54/3,121 Sec#24/266
Total Debt	$728000.00	US#2,992/3,121 Sec#248/266
FCF	$-45M	US#2,515/3,121 Sec#111/266
Cash	$19M	US#2,883/3,121 Sec#260/266
Current Ratio	16.16x	US#155/3,121 Sec#44/266
Performance
1Y Return	105.23%	US#166/3,121 Sec#56/266
1M Return	-18.44%	US#2,825/3,121 Sec#221/266
From 52W High	-53.40%	US#2,806/3,121 Sec#224/266
1Y MDD	-56.43%	US#2,686/3,121 Sec#203/266
Trading
Volume	3,629,323 shares	US#1,046/3,121 Sec#105/266
Trading Value	$45M	US#1,904/3,121 Sec#148/266
Per Share
EPS	$-0.64	US—/3,121 Sec—/266
BPS	$2.68	US#2,523/3,121 Sec#166/266